A prospective study of interstitial, cystitis: Results of longitudinal followup of the interstitial cystitis data base cohort

Citation
Kj. Propert et al., A prospective study of interstitial, cystitis: Results of longitudinal followup of the interstitial cystitis data base cohort, J UROL, 163(5), 2000, pp. 1434-1439
Citations number
21
Categorie Soggetti
Urology & Nephrology","da verificare
Journal title
JOURNAL OF UROLOGY
ISSN journal
00225347 → ACNP
Volume
163
Issue
5
Year of publication
2000
Pages
1434 - 1439
Database
ISI
SICI code
0022-5347(200005)163:5<1434:APSOIC>2.0.ZU;2-3
Abstract
Purpose: We present baseline characteristics and longitudinal profiles of s ymptoms in the Interstitial Cystitis Data Base study, a prospective cohort study of patients with interstitial cystitis. Materials and Methods: A total of 637 eligible patients were entered into t he study and followed for symptoms of pain, urgency and urinary frequency. Median followup was 31 months. Results: More than 90% of patients were white women with a median age of 43 years. Using the overall pain-urgency-frequency score 7% of participants p resented with mild, 44% with moderate and 49% with severe symptoms. Severe urgency in 41% of cases and severe 24-hour frequency in 41% were more commo n than severe pain in 29%, Of the patients 51% reported nighttime frequency of 2 or more voids. Median duration of interstitial cystitis symptoms was 8 years and 68% of participants were previously diagnosed with the conditio n. The 36% of patients who withdrew from study or were lost to followup wer e more likely to have had more severe symptoms at baseline. Patterns of cha nge with time suggest initial symptom improvement due to regression to the mean, and an intervention effect associated with the increased followup and care of cohort participants. Although all symptoms fluctuated, there was n o evidence of significant long-term change in overall disease severity. Conclusions: Our observations support the clinical observation that interst itial cystitis is a chronic disease and no current treatments have a signif icant impact on symptoms with time. These results provide a foundation for the design and performance of future clinical trials in interstitial cystit is using these end points in a similar patient population.